Altis Biosystems To Exhibit At ISSX With RepliGut® Platform

Altis Biosystems will participate in the ISSX 13th International meeting to be held in Seattle September 11–14. 

Altis will be showcasing its RepliGut® platform. RepliGut® Planar is a unique in vitro model of the intestinal epithelium, which provides a critical barrier against luminal pathogens and is essential for efficient nutrient absorption.

Altis Biosystems has created a next-generation in vitro platform that reduces the time and cost of developing safer, more effective drugs.

By replicating native human biology, the intestinal stem cell platform produces more accurate and reproducible data for better clinical trial performance and reduces the need for animal testing.

RepliGut® is a unique, stem cell derived platform that recreates the human small intestine and colonic epithelium for more biologically relevant screening of compounds, disease modeling, and microbiome research.

With a scalable platform, actionable data, high throughput screening to test thousands of compounds, and an unrivaled biobank, RepliGut® is the future of in vitro testing during drug development.The high throughput platform supports quick screening of thousands of candidates and fosters efficient development through reduced timelines and costs. Focus applications include preclinical studies for compound screening, investigating the effects of diseases, and microbiome research.